Efficacy and safety of glycopyrrolate/eFlow ® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials

Published 2017 View Full Article

Authors

Keywords

COPD, eFlow, CS, Glycopyrrolate, Maintenance, Nebulizer, SUN-101

Journal

RESPIRATORY MEDICINE

Volume 132, Issue -, Pages 238-250

Publisher

Elsevier BV

Online

2017-07-20

DOI

10.1016/j.rmed.2017.07.011

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now